Zymeworks Inc $ZYME

Recent News (5)

• Zymeworks options signal bullish surge as $35 September calls dominate Investing.com · 31 Aug 2026 Zymeworks options signal bullish surge as $35 September calls dominate
• H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval Investing.com · 26 Aug 2026 H.C. Wainwright raises Zymeworks stock price target to $55 on FDA approval
• U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma GlobeNewswire · 25 Aug 2026 VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pi…
• Zymeworks stock hits 52-week high at 29.81 USD Investing.com · 25 Aug 2026 Zymeworks stock hits 52-week high at 29.81 USD
• Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab Yahoo Finance · 24 Aug 2026 Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab